PPAR Regulation of Inflammatory Signaling in CNS Diseases

Abstract EN

Central nervous system (CNS) is an immune privileged site, nevertheless inflammation associates with many CNS diseases.

Peroxisome proliferator-activated receptors (PPARs) are a family of nuclear hormone receptors that regulate immune and inflammatory responses.

Specific ligands for PPARα, γ, and δ isoforms have proven effective in the animal models of multiple sclerosis (MS), Alzheimer's disease, Parkinson's disease, and trauma/stroke, suggesting their use in the treatment of neuroinflammatory diseases.

The activation of NF-κB and Jak-Stat signaling pathways and secretion of inflammatory cytokines are critical in the pathogenesis of CNS diseases.

Interestingly, PPAR agonists mitigate CNS disease by modulating inflammatory signaling network in immune cells.

In this manuscript, we review the current knowledge on how PPARs regulate neuroinflammatory signaling networks in CNS diseases.